The Quantellect read.As of Nov 19, 2026, 9 active firms cover Progyny Inc: 7 rate it Buy or better, 2 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $30.00 to $40.00, so the covering firms are broadly aligned. The average target of $34.22 sits 5% below the current $36.15. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.57 next quarter toward $2.40 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 active firms
Buy
Strong Buy00%
Buy778%
Neutral222%
Sell00%
Strong Sell00%
Based on 9 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$34.22
-5.3% downside
Average target across 9 active firms as of Nov 19, 2026 vs $36.15 current
Highest Target$40.00
Average Target$34.22
Lowest Target$30.00
Detailed analyst forecasts for PGNY
Showing 1–10 of 10 named analysts shown · 9 active firms in the rating projection
As of Nov 19, 2026, 7 of 9 active firms rate PGNY a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
PGNY EPS & revenue forecast
EPS · NEXT QUARTER
$0.57
Range $0.55 – $0.61 · 6 analysts · +14% YoY
Next period, 6 analysts expect Progyny Inc to earn $0.57 a share (range $0.55 – $0.61), versus $0.50 a year earlier. Full-year consensus is $2.11, growing to $2.40 the year after.
REVENUE · NEXT QUARTER
$366.0M
Range $360.8M – $375.3M · 6 analysts · +11% YoY
Revenue is expected to reach $366.0M (range $360.8M – $375.3M), +11.4% year-over-year. Full-year consensus is $1.4B, rising to $1.5B next year.
Top analysts covering Progyny Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PGNY.
#1
Sarah James
Cantor Fitzgerald · Rank #159
Buy
$31.00-14.2% to target
Overall win rate
37%
+ Follow
#2
Richard Close
Canaccord Genuity · Rank #249
Buy
$35.00-3.2% to target
Overall win rate
37%
+ Follow
#3
Constantine Davides
JMP Securities · Rank #454
Buy
$38.00+5.1% to target
Overall win rate
32%
+ Follow
#4
Scott Schoenhaus
Keybanc · Rank #540
Buy
$35.00-3.2% to target
Overall win rate
30%
+ Follow
#5
Jailendra Singh
Truist Securities
Buy
$36.00-0.4% to target
Coverage
—
+ Follow
PGNY stock forecast FAQ
What is PGNY's average 12-month price target?+
The 9 active firms with a live target average $34.22 for Progyny Inc over the next 12 months, ranging from a $40.00 high to a $30.00 low, as of Nov 19, 2026.
Is PGNY stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 9 active firms as of Nov 19, 2026, 7 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for PGNY?+
The Street-high target is $40.00 (BTIG), and the Street-low is $30.00 (JP Morgan). The average of all 9 active-firm targets is $34.22.
How many active Wall Street firms cover PGNY?+
9 active firms have a recognized rating on Progyny Inc as of Nov 19, 2026, and 9 active firms carry a live 12-month price target.
Who is the most accurate analyst covering PGNY?+
Among analysts who currently cover PGNY, Sarah James of Cantor Fitzgerald has the strongest overall Quantellect track record (Rank #159). Their current call is Buy with a $31.00 target.
What is Progyny Inc's projected EPS for next quarter?+
The consensus estimate is $0.57 per share (range $0.55 – $0.61) across 6 analysts. Full-year EPS is projected at $2.11, rising to $2.40 the following year.
How much revenue is Progyny Inc expected to report next quarter?+
Consensus revenue is $366.0M (range $360.8M – $375.3M). Full-year revenue is projected at $1.4B, growing to $1.5B next year.
Have analysts been upgrading or downgrading PGNY lately?+
As of Nov 19, 2026, 7 of 9 active firms rate PGNY a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PGNY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.